Painkiller Dangerous for Heart Patients
Posted on: Friday, 6 April 2007, 12:00 CDT
Ibuprofen may increase the likelihood of heart problems in high-risk heart patients who have osteoarthritis, suggests a U.S. study.
Researchers at the Mount Sinai School of Medicine in New York compared cardiovascular health over a one-year period in more than 18,000 patients. The patients, who were older than 50 and had osteoarthritis, were taking part in the Therapeutic Arthritis Research and Gastrointestinal Event Trial.
The study in the Annals of the Rheumatic Diseases found high-risk patients taking aspirin and ibuprofen were about nine times as likely to have heart attacks and strokes over one year as those on the drug lumiracoxib.
The researchers said their findings suggest ibuprofen interferes with the blood thinning properties of aspirin in patients at high risk of cardiovascular disease.
Source: United Press International
Related Articles
- Extreme Glucose Levels In Diabetic Patients With Heart Failure Connected To Increase Risk Of Deaths
- Improving Treatment Of Patients With Heart Attack
- Crowded Emergency Clinics Pose Greater Risks For Patients With Heart Attacks
- Studies Indicate Exercise Training Could Provide Some Benefit For Patients With Heart Failure
- Nile Therapeutics Announces Positive Results from Phase 1b Safety and Pharmacodynamics Study of CD-NP in Patients with Heart Failure
- Lipitor 80 Mg Provided Sustained Risk Reduction of Cardiovascular Events in Patients With Heart Disease During the Five-Year TNT Trial
- Lipitor 80 Mg Reduced the Risk of Heart Attack and Stroke in Patients With Heart Disease, Type 2 Diabetes and Chronic Kidney Disease
- CoGenesys Initiates Phase 1-2 Clinical Trial of Cardeva in Patients With Heart Failure
- US patients with heart failure have better short-term survival rates than Canadian patients
- Amgen Announces Initiation of Phase 3 Trial to Evaluate the Impact of Treating Anemia With Darbepoetin Alfa in Patients With Heart Failure to Reduce Mortality and Hospitalization
User Comments (0)

RSS Feeds